EA202192857A1 - METHODS AND USES OF ICOS VARIANT LIGAND (ICOSL) Fusion Proteins - Google Patents

METHODS AND USES OF ICOS VARIANT LIGAND (ICOSL) Fusion Proteins

Info

Publication number
EA202192857A1
EA202192857A1 EA202192857A EA202192857A EA202192857A1 EA 202192857 A1 EA202192857 A1 EA 202192857A1 EA 202192857 A EA202192857 A EA 202192857A EA 202192857 A EA202192857 A EA 202192857A EA 202192857 A1 EA202192857 A1 EA 202192857A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
icosl
icos
fusion proteins
proteins
Prior art date
Application number
EA202192857A
Other languages
Russian (ru)
Inventor
Райан Свенсон
Цзин Ян
Стенфорд Пэн
Ян Хиллсон
Original Assignee
Элпайн Иммьюн Сайенсиз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Элпайн Иммьюн Сайенсиз, Инк. filed Critical Элпайн Иммьюн Сайенсиз, Инк.
Priority claimed from PCT/US2020/028601 external-priority patent/WO2020214867A1/en
Publication of EA202192857A1 publication Critical patent/EA202192857A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

В изобретении представлены иммуномодулирующие белки, содержащие варианты ICOSL, и нуклеиновые кислоты, кодирующие такие белки. Иммуномодулирующие белки обеспечивают терапевтическую пользу при различных иммунологических и онкологических состояниях. Предлагаются композиции и способы получения и применения таких белков.The invention provides immunomodulatory proteins containing ICOSL variants and nucleic acids encoding such proteins. Immunomodulatory proteins provide therapeutic benefit in a variety of immunological and oncological conditions. Compositions and methods for the production and use of such proteins are provided.

EA202192857A 2020-03-10 2020-04-16 METHODS AND USES OF ICOS VARIANT LIGAND (ICOSL) Fusion Proteins EA202192857A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062987854P 2020-03-10 2020-03-10
PCT/US2020/028601 WO2020214867A1 (en) 2019-04-17 2020-04-16 Methods and uses of variant icos ligand (icosl) fusion proteins

Publications (1)

Publication Number Publication Date
EA202192857A1 true EA202192857A1 (en) 2022-03-21

Family

ID=81077485

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192857A EA202192857A1 (en) 2020-03-10 2020-04-16 METHODS AND USES OF ICOS VARIANT LIGAND (ICOSL) Fusion Proteins

Country Status (1)

Country Link
EA (1) EA202192857A1 (en)

Similar Documents

Publication Publication Date Title
EA202090974A1 (en) VARIANT IMMUNOMODULATING PROTEINS OF ICOS LIGAND AND ACCOMPANYING COMPOSITIONS AND METHODS
NZ746934A (en) Cd80 variant immunomodulatory proteins and uses thereof
CY1124806T1 (en) ENANTI-CD40 ANTIBODIES AND USES THEREOF
CY1122494T1 (en) FUSION PROTEINS COMPRISING A BINDING PROTEIN AND AN INTERLEUKIN-15 POLYPEPTIDE HAVING A REDUCED AFFINITY FOR IL15RA AND THERAPEUTIC USES THEREOF
CY1123274T1 (en) ANTI-OX40 ANTIBODIES AND USES THEREOF
NZ756395A (en) Cd80 variant immunomodulatory proteins and uses thereof
BR112018070934A2 (en) immunomodulatory proteins, single ligand variants and uses thereof
BR112018011073A2 (en) anti-myostatin antibodies, polypeptides containing variant regions and methods of use
BR112018004965A2 (en) Adjustable variant immunoglobulin superfamily domains
EA201990017A1 (en) ANTIBODIES TO MYOSTATIN AND WAYS OF THEIR APPLICATION
MD3512543T2 (en) Trimer stabilizing HIV envelope protein mutations
EA201991168A1 (en) PROTEIN BINDING PROSTATIC SPECIFIC MEMBRANE ANTIGEN
EA201892561A1 (en) HYBRID PROTEINS GDF15 AND THEIR APPLICATION
EA201890423A1 (en) SLIGHT PROTEINS OF THE FACTOR IX, METHODS OF THEIR RECEPTION AND APPLICATION
BR112017006736A2 (en) antimostatin antibodies, polypeptides containing variant fc regions, and methods of use
EA201791562A1 (en) CYTOMEGALOVIRUS ANTIGENS AND THEIR APPLICATIONS
MX2021012607A (en) Methods and uses of variant icos ligand (icosl) fusion proteins.
NZ756392A (en) Pd-l1 variant immunomodulatory proteins and uses thereof
CY1112924T1 (en) JNK Cell Signaling Disruptions
SG10201903142RA (en) Serpin fusion polypeptides and methods of use thereof
EA202090084A1 (en) NEW THERAPEUTIC ENZYME Fusion PROTEIN AND ITS APPLICATION
EA201891141A1 (en) NEW ANTIANGIOGENIC FUSED POLYPEPTIDES
WO2018067582A3 (en) Hiv-1 env fusion peptide immunogens and their use
MX2021001129A (en) Antigen purification method.
WO2020113141A3 (en) Cd86 variant immunomodulatory proteins and uses thereof